Skip to Main Content

Paper Details

Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancer.
Prostate Cancer Prostatic Dis
4
2021
PATIENT, SPOP, SPOP mutation, advanced prostate cancer, androgen, androgen-receptor, cancer, genomic lesions, man, men, metastatic prostate cancer, oligometastastic hormone-sensitive prostate cancer, patient, prostate-cancer, tumor
Author NameAffiliation
Shantao LiYale University
Kenneth EngEnglander Institute for Precision Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Andrea SbonerEnglander Institute for Precision Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Meyer Cancer Center, Weill Cornell Medical College
Andrea SbonerEnglander Institute for Precision Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Meyer Cancer Center, Weill Cornell Medical College
Mark A RubinEnglander Institute for Precision Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Meyer Cancer Center, Weill Cornell Medical College
Mark A RubinBern Center for Precision Medicine, University of Bern and Inselspital
Mark A RubinUniversity of Bern and Inselspital
Mark A RubinEnglander Institute for Precision Medicine, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Meyer Cancer Center, Weill Cornell Medical College
Mark A RubinUniversity of Bern and Inselspital
Mark A RubinBern Center for Precision Medicine, University of Bern and Inselspital
Mark GersteinYale University
Mark GersteinYale University
Mark GersteinYale University
Mark GersteinYale University
  • 1 - 14

Datasets

Release 1.2